BR112013011881A2 - non-replicating probiotic microorganisms that protect against upper respiratory tract infections - Google Patents

non-replicating probiotic microorganisms that protect against upper respiratory tract infections

Info

Publication number
BR112013011881A2
BR112013011881A2 BR112013011881A BR112013011881A BR112013011881A2 BR 112013011881 A2 BR112013011881 A2 BR 112013011881A2 BR 112013011881 A BR112013011881 A BR 112013011881A BR 112013011881 A BR112013011881 A BR 112013011881A BR 112013011881 A2 BR112013011881 A2 BR 112013011881A2
Authority
BR
Brazil
Prior art keywords
respiratory tract
protect against
upper respiratory
tract infections
probiotic microorganisms
Prior art date
Application number
BR112013011881A
Other languages
Portuguese (pt)
Inventor
Annick Mercenier
Clara Lucia Garcia-Rodenas
Guénolée PRIOULT
Monique Julita
Sophie Nutten
Valérie PETIT
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43645899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013011881(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112013011881A2 publication Critical patent/BR112013011881A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112013011881A 2010-11-11 2011-11-09 non-replicating probiotic microorganisms that protect against upper respiratory tract infections BR112013011881A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10190819A EP2455092A1 (en) 2010-11-11 2010-11-11 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
PCT/EP2011/069692 WO2012062780A1 (en) 2010-11-11 2011-11-09 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

Publications (1)

Publication Number Publication Date
BR112013011881A2 true BR112013011881A2 (en) 2016-11-01

Family

ID=43645899

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013011881A BR112013011881A2 (en) 2010-11-11 2011-11-09 non-replicating probiotic microorganisms that protect against upper respiratory tract infections

Country Status (12)

Country Link
US (2) US9370538B2 (en)
EP (2) EP2455092A1 (en)
CN (1) CN103547276A (en)
AU (1) AU2011328136A1 (en)
BR (1) BR112013011881A2 (en)
CA (1) CA2817689A1 (en)
CL (1) CL2013001316A1 (en)
IL (1) IL226212A0 (en)
MX (1) MX2013005371A (en)
RU (1) RU2589706C2 (en)
SG (2) SG190215A1 (en)
WO (1) WO2012062780A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN105722515A (en) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 Compositions for use in the prevention or treatment of URT infections in infants or young children at risk
CN104886255B (en) * 2014-03-07 2018-11-27 内蒙古伊利实业集团股份有限公司 Have effects that alleviate the probiotic food composition and food of bottleneck throat inflammation
WO2015140299A1 (en) 2014-03-20 2015-09-24 Universiteit Antwerpen Oronasopharyngeal probiotics
JP6427278B2 (en) 2014-12-23 2018-11-21 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ pirin polypeptide and immune modulation
EP3395351A1 (en) 2014-12-23 2018-10-31 4D Pharma Research Limited Immune modulation
BR112017025005A2 (en) 2015-06-15 2018-08-07 4D Pharma Research Limited compositions comprising bacterial strains
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
CN107847529B (en) 2015-06-15 2022-05-03 4D制药研究有限公司 Compositions comprising bacterial strains
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
PT3650033T (en) 2015-06-15 2022-05-25 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108367033A (en) * 2015-08-31 2018-08-03 雀巢产品技术援助有限公司 The method and composition of depressive symptom is treated or prevented using bifidobacterium longum
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41013A (en) 2015-11-20 2017-08-30 4D Pharma Res Ltd COMPOSITIONS CONTAINING BACTERIAL STRAINS
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
EA035949B1 (en) 2016-03-04 2020-09-04 4Д ФАРМА ПиЭлСи Use of a composition comprising bacterial blautia hydrogenotrophica strain and method of treating or preventing visceral hypersensitivity
CN106176820A (en) * 2016-07-12 2016-12-07 成都圣凯生物科技有限公司 A kind of probiotics preparation improving upper respiratory tract microecological balance and preparation method thereof
TW201821093A (en) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 Compositions comprising bacterial strains
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018158309A1 (en) * 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
KR20190123267A (en) 2017-02-28 2019-10-31 앨러멘터리 헬스 리미티드 Bifidobacterium longgum beneficially modulates the immune response to respiratory viral infections
MA48939B1 (en) 2017-05-22 2021-06-30 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2018215782A1 (en) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strain
LT3638271T (en) 2017-06-14 2021-01-11 4D Pharma Research Limited Compositions comprising bacterial strains
MD3600364T2 (en) 2017-06-14 2020-12-31 4D Pharma Res Ltd Compositions comprising a bacterial strain of the genus Megasphaera and uses thereof
HUE053488T2 (en) 2017-06-14 2021-06-28 4D Pharma Res Ltd Compositions comprising bacterial strains
CN107213338A (en) * 2017-07-19 2017-09-29 颐和益生（北京）科技有限公司 A kind of anti-fog haze composition with preventing respiratory tract infection, preparation method and application
CN108004189B (en) * 2018-01-18 2021-07-27 北京科拓恒通生物技术股份有限公司 Composite probiotic lactic acid bacteria powder and preparation method and application thereof
JP7013419B2 (en) * 2019-08-07 2022-02-15 日清食品ホールディングス株式会社 Bifidobacterium with low inflammatory cytokine production-inducing activity but high anti-inflammatory cytokine production-inducing activity
CN111529703B (en) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 Composition, preparation method thereof and application thereof in preparation of immunoadjuvant
CN113249244B (en) * 2021-03-25 2022-10-14 上海理工大学 Lactobacillus paracasei for antagonizing pharyngitis pathogenic bacteria beta hemolytic streptococcus
MX2023014611A (en) * 2021-07-09 2024-03-01 Simone Claudio De Species, strains and compositions of lactic acid bacteria capable of modulating body oxygenation by increasing hif-1î± levels.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69219768T2 (en) 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milk bacteria
AU1201801A (en) * 1999-10-15 2001-08-07 Van Kampen Group, Inc., The Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
FR2809312B1 (en) * 2000-05-25 2002-07-12 Gervais Danone Sa USE OF L. CASEI IN IMMUNOSTIMULATING COMPOSITIONS
US20050180962A1 (en) * 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
RU2258524C2 (en) * 2003-10-23 2005-08-20 Закрытое акционерное общество "Партнер" Composition for treatment of acute respiratory diseases of hib-etiology in children and method for treatment
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
WO2006124630A2 (en) * 2005-05-13 2006-11-23 New England Medical Center Hospitals, Inc. Compositions and methods for enhancing the efficacy of vaccines
ATE551063T1 (en) * 2006-02-15 2012-04-15 Nestec Sa USE OF BIFIDOBACTERIUM LONGUM FOR PROPHYLAXIS AND TREATMENT OF INFLAMMATION
KR101474188B1 (en) 2006-10-02 2014-12-17 듀폰 뉴트리션 바이오사이언시즈 에이피에스 Probiotics for use in reducing the incidence and duration of illness
WO2008053444A2 (en) * 2006-11-01 2008-05-08 The Procter & Gamble Company Treating a respiratory condition with bifidobacterium
WO2008106372A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Method for treating or preventing systemic inflammation
WO2009071086A2 (en) * 2007-12-06 2009-06-11 Arla Foods Amba Probiotic bacteria and regulation of fat storage
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
PT2429539T (en) * 2009-05-11 2017-01-12 Nestec Sa Non-replicating lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children

Also Published As

Publication number Publication date
AU2011328136A1 (en) 2013-05-30
RU2013126599A (en) 2014-12-20
IL226212A0 (en) 2013-07-31
US9370538B2 (en) 2016-06-21
MX2013005371A (en) 2013-06-28
SG190215A1 (en) 2013-06-28
US20160250265A1 (en) 2016-09-01
CL2013001316A1 (en) 2013-10-18
SG10201508826YA (en) 2015-11-27
EP2455092A1 (en) 2012-05-23
CN103547276A (en) 2014-01-29
CA2817689A1 (en) 2012-05-18
EP2637678A1 (en) 2013-09-18
US20130224253A1 (en) 2013-08-29
WO2012062780A1 (en) 2012-05-18
RU2589706C2 (en) 2016-07-10

Similar Documents

Publication Publication Date Title
BR112013011881A2 (en) non-replicating probiotic microorganisms that protect against upper respiratory tract infections
IL227193B (en) Plant extracts for the treatment and prevention of infections
HUE037860T2 (en) Heterocycle amines and uses thereof
EP2660254A4 (en) Vinylidene-fluoride-based copolymer and application of said copolymer
PL2944690T3 (en) Novel fucosyltransferases and their applications
HK1185368A1 (en) Heat-curable polyorganosiloxane composition and use thereof
HRP20160922T1 (en) Oligopeptidic compounds and uses thereof
HK1179981A1 (en) Antibodies against il-18r1 and uses thereof il-18r1
EP2566957B8 (en) Vaccine against beta-herpesvirus infection and use thereof
PT2575971E (en) Combined plant extracts for use in the treatment of microbial infections
CL2013001315A1 (en) Composition comprising extruded non-replicating probiotic micro-organisms.
EP2608785A4 (en) Lipomacrocycles and uses thereof
BR112013011759A2 (en) Non-replicating probiotic microorganisms protect children against gastrointestinal infections
EP2627391A4 (en) Hydrophobic catheter and composition
HK1184779A1 (en) Novel compound and medical use thereof
EP2529013A4 (en) Novel -glucosidase and uses thereof
FR2962511B1 (en) IMPROVED VALVE, AND APPLICATION
BR112013010195A2 (en) "packing"
EP2650292A4 (en) Thiazolamine derivative and use thereof as anti-picornaviral infection medicament
FR2962509B3 (en) SEALING ELEMENT
BR112013011091A2 (en) Sweet rice preparations containing probiotic microorganisms
GB201003873D0 (en) Flexible membrane and application
UA22020S (en) RESPIRATOR
TH149334B (en) "Elements that destroy microorganisms"
GB201014319D0 (en) Compounds and uses thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2435 DE 05-09-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.